FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

1,063 letters match. Newest first.

  1. Shoolin Pharma Chem LLP

    Shoolin Pharma Chem, an Indian API maker, warned over filthy conditions, missing test data, and cleaning failures; all U.S. APIs recalled.

    High risk
  2. B&P Mutual Corp

    B&P Mutual Corp lacked required FSVP records for imported syrup, molasses, and chocolate-free candy, FDA says.

    Medium
  3. Mesquite Gourmet LLC

    Mesquite Gourmet lacked required foreign supplier verification for imported fresh peppers, FDA says.

    Medium
  4. R3 Medical Companies

    FDA cites R3 Medical affiliates for selling unapproved umbilical cord and exosome biologics without licenses and with serious manufacturing violations.

    High risk
  5. Suretec Innovations, LLC

    Suretec Innovations failed manufacturing quality rules for OTC sanitizing wipes and did not list a private-label wipe.

    High risk
  6. Eugia Pharma Specialities Limited

    FDA warned Eugia Pharma Specialities that flawed aseptic line design and poor aseptic practices at its Kolthur Village plant risk contaminating sterile injectables.

    High risk
  7. K.C. Pharmaceuticals, Inc.

    FDA cited K.C. Pharmaceuticals of Pomona, CA, for sterile-drug manufacturing failures, including aseptic practice problems and failed media fills.

    High risk
  8. Safrel Pharmaceuticals LLC

    FDA warned Safrel Pharmaceuticals, an OTC drug labeler in Dayton, New Jersey, that it lacked quality oversight of its suppliers and shipped adulterated drugs.

    High risk
  9. Nipro Renal Solutions USA, Corporation

    Nipro Renal Solutions USA released hemodialysis dialysate lots with out-of-spec endotoxin (bacterial toxin) and had widespread quality-system failures, FDA says.

    High risk
  10. Waves and Wine, Inc.

    FDA warns Waves and Wine, a California raw pet food maker, over Listeria in its beef pet foods and inadequate food safety controls.

    High risk
  11. FairyGene, Inc.

    FDA cites FairyGene, a Bristol, PA contract manufacturer, for unsanitary facility and cleaning practices and for selling five unapproved drug balms.

    High risk
  12. Woodbine Products Company Inc.

    Inspection found Woodbine Products, an Ohio OTC drug maker, failed to test incoming ingredients like glycerin and propylene glycol for identity.

    High risk
  13. Thomas Brunner Hygiene GmbH

    Thomas Brunner Hygiene GmbH's syNeo antiperspirants are unapproved new drugs and were made without adequate manufacturing testing and validation.

    High risk
  14. Dabur India Limited

    FDA cites Dabur India for falsified records, incomplete lab data, and inadequate cleaning and process validation for over-the-counter drugs.

    High risk
  15. Friend’s Stable and Orchard, Inc.

    FDA warns Friend’s Stable and Orchard that raw manure touching growing citrus violates produce safety rules.

    High risk
  16. Eherbs Imports, Inc

    FDA warns Eherbs Imports it lacked required foreign supplier verification for imported bread, string cheese, and amaranth candy.

    Medium
  17. San Jorge Produce LLC

    FDA warns San Jorge Produce LLC it lacked foreign supplier verification programs for several imported produce items.

    Medium
  18. Piquin Y Sabores Distributors LLC

    FDA warns Piquin Y Sabores Distributors over missing foreign supplier verification program for imported corn chips and granola.

    Medium
  19. Delight Distribution Inc.

    Delight Distribution lacked required checks on imported foods, including canned chickpeas, FDA says.

    Medium
  20. Prida Import & Export LLC

    Prida Import & Export lacked FSVP for imported powdered milk, cilantro sauce, and candy, FDA says.

    Medium
  21. Island Kinetics, Inc. d.b.a. CoValence Laboratories

    Island Kinetics (CoValence Laboratories) made OTC acne drugs without process validation and shipped unapproved, misbranded acne products.

    High risk
  22. BioMylz Pvt. Ltd.

    FDA found destroyed records, inadequate process and cleaning validation, missing microbial testing, and incomplete drug listings at BioMylz, an Indian OTC drug manufacturer.

    High risk
  23. IJAJ Group Inc DBA Sanz Wholesale Foods

    FDA warns Sanz Wholesale Foods it lacked an FSVP for imported foods, including cookies.

    Medium
  24. Balkanica LLC

    FDA warns Balkanica LLC over missing foreign supplier verification program for imported Bulgarian sunflower seeds and sheep’s milk cheese.

    Medium
  25. Fareva Amboise

    FDA warned Fareva Amboise in France about sterile drug manufacturing failures, including aseptic practice and data integrity problems.

    High risk
  26. Spa De Soleil, Inc.

    FDA cites Spa De Soleil for CGMP violations in OTC topical drugs, including water system failures and missing component identity testing.

    High risk
  27. International Medication Systems Limited

    FDA found insect larvae and heavy microbial growth in International Medication Systems' sterile filling area; its epinephrine injection lot was later recalled.

    High risk
  28. Win Woo Trading, LLC / HF Foods Group

    FDA says Win Woo Trading did not develop FSVP for imported gelatin, starches, sugars, teas, rice, beans, and beverage powders.

    Medium
  29. Diamond Distributions LLC

    Diamond Distributions LLC lacked a Foreign Supplier Verification Program for imported chocolate products, FDA found after a May 2026 inspection.

    Medium
  30. Bushman Organic Farms, Inc.

    Bushman Organic Farms, an Iowa importer, had no FSVP records for organic soybean meal from 11 foreign suppliers.

    Medium
  31. Excelvision - Fareva

    FDA warned Excelvision-Fareva after a 2026 inspection found inadequate contamination investigations and aseptic failures for sterile drugs.

    High risk
  32. Wizcure Pharmaa Private Limited

    FDA warned Wizcure Pharmaa about serious manufacturing and data-integrity failures in sterile OTC drugs.

    High risk
  33. Life & Food Inc.

    FDA: Life & Food Inc., a Las Vegas matcha and green tea importer, had no FSVP (importer safety plan) for any food it imports.

    Medium
  34. 3B Medical, Inc. dba Reach Health, Inc.

    FDA warns Reach Health over unapproved APAP use change and complaint/CAPA failures.

    High risk
  35. Leading Edge Health Inc.

    FDA told Leading Edge Health its Erectin Stimulating Gel and VigRX Delay Wipes are unapproved new drugs based on claims on its website.

    Medium
  36. Indiangoods.shop

    FDA warned website Indiangoods.shop that three herbal sexual-performance capsules it sells are unapproved new drugs.

    Medium
  37. Huons Co., Ltd.

    FDA cites Huons in South Korea for data integrity and sterility failures in drug manufacturing.

    High risk
  38. Vivot LLC

    FDA warns Vivot LLC it lacked required foreign supplier food-safety checks for imported matcha and green tea.

    Medium
  39. Imu-Tek Animal Health, Incorporated

    FDA warns Imu-Tek Animal Health over unapproved drug claims and manufacturing failures for Colostrom-5 products.

    High risk
  40. Jubilant HollisterStier General Partnership

    FDA found sterile drug manufacturing and investigation failures at Jubilant HollisterStier in Kirkland.

    High risk
  41. Global Imports Origins

    FDA warns Global Imports Origins of Houston, TX, for lacking a foreign supplier verification program for imported Red Pepper.

    Medium
  42. NativeMed LLC dba NativeMed

    FDA warned telehealth seller NativeMed that its website misbranded compounded semaglutide and tirzepatide with false or misleading claims.

    Low
  43. HydraMed IV LLC dba HydraMed

    FDA told Denver telehealth seller HydraMed its website misbrands compounded semaglutide and tirzepatide with false or misleading claims.

    Low
  44. Nexus Health Solutions LLC dba Harper Meds

    FDA warned telehealth seller Harper Meds that its website misbrands compounded semaglutide and tirzepatide with false and misleading claims.

    Low
  45. Trinity HealthCare Supply, LLC dba altRx

    FDA warns altRx over misleading website claims for compounded semaglutide and tirzepatide, including 'clinically proven' and wrong compounder label.

    Low
  46. YS Group Inc.

    YS Group Inc. of Arcadia, CA, imported tofu skin, dried seaweed and buckwheat flour without any FSVP, FDA says.

    Medium
  47. Amie Health, Inc. dba Amie

    FDA warned telehealth seller Amie Health that its website misbrands compounded semaglutide and tirzepatide with false and misleading claims.

    Medium
  48. Thrivelab Co. dba Thrivelab

    FDA warned telehealth seller Thrivelab that its website misbrands compounded semaglutide with false claims suggesting FDA approval.

    Medium
  49. VivioMD Group LLC dba VivioMD

    FDA warned VivioMD that its website misbrands compounded semaglutide and tirzepatide by implying VivioMD is the compounder.

    Low
  50. Glow Medispa, LLC dba Mint Med

    FDA warns telehealth seller Mint Med that its website labels falsely suggest it compounds the semaglutide and tirzepatide drugs it sells.

    Low